Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Bayer : Germany to Ban Glyphosate From End of 2023 -- Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/04/2019 | 08:23am EDT

(Updates with Bayer statement)

 
   By Kim Richters and Andrea Thomas 
 

Germany dealt another blow to Bayer AG's (BAYN.XE) controversial Roundup herbicide Wednesday, saying it planned a complete ban on the key ingredient glyphosate from the end of 2023 as part of an environmental protection program.

The government said the plan would help address concerns about the decreasing number and variety of insects in Germany. The ban, part of a program agreed by the government on Wednesday, aims to protect insects by eliminating the use of glyphosate, which reduces insects' food source by killing plants.

The controversial herbicide is best known for being used in the weedkiller Roundup, a product produced by Monsanto, the U.S. chemical company that Bayer acquired in 2018. The companies are facing lawsuits from more than 18,000 plaintiffs alleging that the product causes cancer.

The planned ban is the latest in a string of restrictions on the herbicide. While Austria banned the chemical in July, a number of other countries, including France and Colombia, have also placed restrictions on its use. However, it is approved until the end of 2022 in Europe.

In response to the German cabinet's agreement, Bayer said that it disagreed with the government's decision to completely ban the herbicide.

"The ruling ignores decades of scientific judgment from independent regulatory agencies around the world that glyphosate is safe when used properly," said Liam Condon, member of the Bayer management board and president of its crop science division.

"Regardless of a ban of glyphosate farmers will still have to control weeds to ensure their harvests. Therefore the amount of forage for insects will not change whatever method is used," the company said. According to Bayer, the sales share of glyphosate in Germany is less than 5% of its German crop-science unit.

As part of the program, the German government will make 100 million euros ($109.5 million) available annually for insect protection and research efforts. Germany also plans to reduce the use of glyphosate significantly in the period leading up to the ban.

Write to Kim Richters at kim.richters@wsj.com and Andrea Thomas at andrea.thomas@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
09/11BAYER : opens application window for Grants4Traits™ and Grants4Biologicals..
PU
09/10BAYER : to reduce size of management board to five
RE
09/10BAYER : to Reduce Size of Management Board
DJ
09/10BAYER : reduces size of Board of Management from seven to five members
PU
09/10BAYER : launches latest fungicide innovation, iblon™ technology
PU
09/10Elliott Appears to Revert to Old Form -- WSJ
DJ
09/09Big Ag wants a cut of booming fake-meat market
RE
09/09Germany Offers a Model to Corporate America on Labor Relations
DJ
09/06BAYER : Yields more than doubled during 4-year project with smallholder farmers
PU
09/06BAYER : Counters Accusations Involving Monsanto Weedkiller
DJ
More news
Financials (EUR)
Sales 2019 46 067 M
EBIT 2019 8 274 M
Net income 2019 3 199 M
Debt 2019 37 472 M
Yield 2019 4,17%
P/E ratio 2019 21,2x
P/E ratio 2020 13,9x
EV / Sales2019 2,19x
EV / Sales2020 2,06x
Capitalization 63 469 M
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 78,94  €
Last Close Price 68,15  €
Spread / Highest target 80,5%
Spread / Average Target 15,8%
Spread / Lowest Target -43,1%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG12.38%70 287
JOHNSON & JOHNSON1.07%345 150
ROCHE HOLDING LTD.10.52%236 116
MERCK AND COMPANY8.11%211 513
PFIZER-15.44%204 151
NOVARTIS18.45%200 777